Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy

Michael Firer

Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy

Department of Chemical Engineering

Research output: Book/Report › Report › peer-review

Original language	English
Place of Publication	Basel
Number of pages	157
State	Published - 30 Apr 2016

Keywords

biology of drug delivery via carrier-drug conjugates
overcoming cancer cell drug resistance with carrier-drug conjugates
carrier alternatives—antibodies, peptides, proteins, small ligands, nanostructures
technologies for discovering novel targeting agents
carrier-drug conjugation chemistries
manufacturing and regulatory issues of carrier-drug conjugates
clinical experience with carrier-drug conjugates for cancer therapy
expanding the clinical opportunities for carrier-drug conjugates

Access to Document

https://www.mdpi.com/journal/biomedicines/special_issues/drug_conjugates

Cite this

@book{680b7a39261b4b86af6994825b419c62,

title = "Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy",

keywords = "biology of drug delivery via carrier-drug conjugates, overcoming cancer cell drug resistance with carrier-drug conjugates, carrier alternatives—antibodies, peptides, proteins, small ligands, nanostructures, technologies for discovering novel targeting agents, carrier-drug conjugation chemistries, manufacturing and regulatory issues of carrier-drug conjugates, clinical experience with carrier-drug conjugates for cancer therapy, expanding the clinical opportunities for carrier-drug conjugates",

author = "Michael Firer",

year = "2016",

month = apr,

day = "30",

language = "English",

isbn = "2227-9059",

}

TY - BOOK

T1 - Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy

AU - Firer, Michael

PY - 2016/4/30

Y1 - 2016/4/30

KW - biology of drug delivery via carrier-drug conjugates

KW - overcoming cancer cell drug resistance with carrier-drug conjugates

KW - carrier alternatives—antibodies, peptides, proteins, small ligands, nanostructures

KW - technologies for discovering novel targeting agents

KW - carrier-drug conjugation chemistries

KW - manufacturing and regulatory issues of carrier-drug conjugates

KW - clinical experience with carrier-drug conjugates for cancer therapy

KW - expanding the clinical opportunities for carrier-drug conjugates

M3 - Report

SN - 2227-9059

BT - Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy

CY - Basel

ER -